ResMed stock trades at USD 221.89 after RBC target hike
Published on 09/25/2026 at 12:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
ResMed stock (ISIN US7611521078) was trading at USD 221.89 on Nasdaq on September 24, 2026, down 0.18 percent from the prior close. The latest analyst move came from RBC Capital on September 15, when the firm upgraded ResMed to Outperform and lifted its price target from USD 244 to USD 262.
RBC raises the target
As Investing.com reported on September 15, 2026, RBC Capital analyst Craig Wong-Pan moved the rating from Sector Perform to Outperform. The new USD 262 target lies 18.07 percent above the September 24 price, giving the upgrade a measurable valuation reference.
The broader analyst picture is more restrained. MarketBeat reported a consensus Hold rating and an average target of USD 240.31 on September 10, 2026, below the RBC target but above the quoted share price.
Revenue reaches USD 1.46 billion
According to MarketBeat, ResMed reported USD 1.46 billion in revenue and USD 2.95 in EPS for the quarter ended June 30, 2026. Revenue increased 8.6 percent year over year, while EPS exceeded the USD 2.89 consensus by USD 0.06.
The same report said ResMed raised its quarterly dividend from USD 0.60 to USD 0.66 per share. That change adds a separate shareholder-return signal to the growth case, although the Hold consensus shows that analysts remain divided over valuation and competitive pressure.
Stock remains below yearly high
ResMed's market capitalization stood at USD 32,186,561,046 on September 24, 2026. The 52-week range was USD 180.27 to USD 284.87, placing the latest price USD 62.98 below the yearly high and USD 41.62 above the yearly low.
Trading volume was 754,305 shares on the same session, against an average volume of 1,449,661 shares. The combination of a positive earnings comparison, a higher dividend and the RBC upgrade gives the stock several quantified reference points, while the gap to the 52-week high keeps valuation sensitivity visible.
ResMed stock stays at USD 221.89
ResMed stock was trading at USD 221.89 on Nasdaq on September 24, 2026 at 4:00 p.m. ET, with a daily change of -0.18 percent.
ResMed Inc. stock facts
- Company: ResMed Inc.
- ISIN: US7611521078
- Ticker: RMD
- Trading venue: Nasdaq
- Price (as of September 24, 2026, 4:00 p.m. ET): USD 221.89
- Market capitalization: USD 32,186,561,046 (as of September 24, 2026)
- 52-week range: USD 180.27-284.87 (as of September 24, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
